2013
DOI: 10.1016/j.biomaterials.2012.11.045
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
40
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 44 publications
(45 citation statements)
references
References 42 publications
5
40
0
Order By: Relevance
“…Tissue engineering-based research in both two-dimensional (2D) and three-dimensional cocultures in vitro revealed that the active interaction between ECs and MSCs (or osteoprogenitor and fibroblast) induced the formation of tube-like cell aggregation structures. This result indicates that angiogenesis and prevascularization are involved in the cellcell communication and remodeling of the functional blood vessel development in vivo [5,[18][19][20][21][22][23][24][25][26]. Moreover, MSCs could repress ECs by regulating cytokine-induced leukocyte recruitment [27], while the activated ECs could regulate the MSCs-to-ECs transmigration in a leukocyte-like mechanism [28,29].…”
mentioning
confidence: 99%
“…Tissue engineering-based research in both two-dimensional (2D) and three-dimensional cocultures in vitro revealed that the active interaction between ECs and MSCs (or osteoprogenitor and fibroblast) induced the formation of tube-like cell aggregation structures. This result indicates that angiogenesis and prevascularization are involved in the cellcell communication and remodeling of the functional blood vessel development in vivo [5,[18][19][20][21][22][23][24][25][26]. Moreover, MSCs could repress ECs by regulating cytokine-induced leukocyte recruitment [27], while the activated ECs could regulate the MSCs-to-ECs transmigration in a leukocyte-like mechanism [28,29].…”
mentioning
confidence: 99%
“…The transplantation of various types of cells with angiogenic potential, such as endothelial progenitor cells or stem cells, has shown great promise for treating peripheral arterial disease by the stimulation of new vessel formation [21,22]. However, conventional methods for the delivery of therapeutic cells rely on the direct or systemic injection of cell suspensions with a syringe needle, which is problematic due to the fast leakage of suspended cells, cell death, and low engraftment efficiency [9,23e25].…”
Section: Discussionmentioning
confidence: 99%
“…In this pilot study, a dose-dependent positive correlation was seen with limb reperfusion and the cell mass injected into the adductor muscle of a PAD mouse model, but especially pronounced in diabetic mice. Innovative approaches based on tissue transferprinting [120] of myoblast monolayers as well as three-dimensional aggregates of human umbilical vein endothelial cells and cord-blood mesenchymal stem cells [121] have demonstrated promise towards hastening tube formation.…”
Section: Future Directions and Considerationsmentioning
confidence: 99%